MELBOURNE, Australia, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based developer of...
- A seasoned healthcare executive with nearly two decades of leadership experience, Mr. Jovan Hollins will lead ClinNEXUS’ operations at...
KAI 12L, the AI powering Kardia 12L, adds five new detections to further expand diagnostic capabilities for the world's first...
AMAR regulatory approval will allow the Company to launch ZSmile in Israel in 2026 as a precursor to a larger...
Nu-Tek Manufacturing Facility Nu-Tek's state-of-the-art facility, purpose built to provide over 2000 metric tons of animal-free production annually. Nu-Tek BioSciences...
– Annamycin consistently demonstrates no evidence of cardiotoxicity across five clinical trials – This next-generation anthracycline demonstrates safety and promising...
CEO Highlights Significant Progress Achieved & Outlines Ambitious Plans for 2026MELBOURNE, Australia, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma,...
Company Remains Fully Committed to Advancing Its Core Intranasal Medical Pipeline, alongside examining new opportunities including in fields of aviation,...
Anticipated strong revenue growth driven by higher unit sales of SSi Mantra surgical robotic systemFORT LAUDERDALE, Fla., Jan. 13, 2026...
Cherry Hill, NJ, Jan. 13, 2026 (GLOBE NEWSWIRE) -- LifeRx, a trusted telehealth and wellness company specializing in metabolic, hormonal,...
The minimally dilutive funding will accelerate Pelthos’ highly successful commercialization efforts for its lead product, ZELSUVMI™ (berdazimer) topical gel, 10.3%...
TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a...
LIS Technologies closes 240% oversubscribed funding round of $17 Million, Totaling $64 Million.Oak Ridge, Tennessee--(Newsfile Corp. - January 13, 2026)...
BEIJING, China, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the “Company” or “Pheton”), a healthcare solution provider specializing...
SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
Fourth quarter results represent highest quarterly revenue in Company’s historyQ4 year-over-year growth of 35% to 39% driven by sales execution...
VALENCIA, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound...
BOCA RATON, FL / ACCESS Newswire / January 13, 2026 / Infrastructure narratives are easy to tell. Execution narratives are...
Evaxion adds autoimmune disease as a third disease area as it expands its therapeutic focusIn future, Evaxion’s proprietary AI-Immunology™ platform...
In 2025, Vheda Health achieved its largest growth on record - launching its chronic, behavioral health, and maternity programs across...